First-in-human clinical trial for a vaccine to treat opioid use disorders enrolls first patients
First ever trial to study a therapeutic vaccine for opioid use disorder developed by researchers at the University of Minnesota.
The Brighter Side of News features good news, compassionate news and inspirational news from around the world